232 related articles for article (PubMed ID: 1638517)
1. The growth inhibitory action of melatonin on human breast cancer cells is linked to the estrogen response system.
Hill SM; Spriggs LL; Simon MA; Muraoka H; Blask DE
Cancer Lett; 1992 Jul; 64(3):249-56. PubMed ID: 1638517
[TBL] [Abstract][Full Text] [Related]
2. Anti-proliferative and anti-estrogenic effects of ICI 164,384 and ICI 182,780 in 4-OH-tamoxifen-resistant human breast-cancer cells.
Coopman P; Garcia M; Brünner N; Derocq D; Clarke R; Rochefort H
Int J Cancer; 1994 Jan; 56(2):295-300. PubMed ID: 8314314
[TBL] [Abstract][Full Text] [Related]
3. Altered expression of estrogen-regulated genes in a tamoxifen-resistant and ICI 164,384 and ICI 182,780 sensitive human breast cancer cell line, MCF-7/TAMR-1.
Lykkesfeldt AE; Madsen MW; Briand P
Cancer Res; 1994 Mar; 54(6):1587-95. PubMed ID: 8137264
[TBL] [Abstract][Full Text] [Related]
4. Human breast cancer cell lines resistant to pure anti-estrogens are sensitive to tamoxifen treatment.
Lykkesfeldt AE; Larsen SS; Briand P
Int J Cancer; 1995 May; 61(4):529-34. PubMed ID: 7759159
[TBL] [Abstract][Full Text] [Related]
5. Effects of 4-hydroxytamoxifen and a novel pure antioestrogen (ICI 182780) on the clonogenic growth of human breast cancer cells in vitro.
DeFriend DJ; Anderson E; Bell J; Wilks DP; West CM; Mansel RE; Howell A
Br J Cancer; 1994 Aug; 70(2):204-11. PubMed ID: 8054267
[TBL] [Abstract][Full Text] [Related]
6. [Antitumor activity of miproxifene phosphate (TAT-59) against human mammary carcinoma].
Toko T; Saito H; Fujioka A; Nukatuka M; Sato K; Hashimoto A; Shibata J; Yamada Y
Gan To Kagaku Ryoho; 1998 May; 25(6):829-38. PubMed ID: 9617321
[TBL] [Abstract][Full Text] [Related]
7. Bidirectional interactions between the estrogen receptor and the cerbB-2 signaling pathways: heregulin inhibits estrogenic effects in breast cancer cells.
Grunt TW; Saceda M; Martin MB; Lupu R; Dittrich E; Krupitza G; Harant H; Huber H; Dittrich C
Int J Cancer; 1995 Nov; 63(4):560-7. PubMed ID: 7591267
[TBL] [Abstract][Full Text] [Related]
8. Growth inhibition of estrogen receptor-positive and aromatase-positive human breast cancer cells in monolayer and spheroid cultures by letrozole, anastrozole, and tamoxifen.
Kijima I; Itoh T; Chen S
J Steroid Biochem Mol Biol; 2005 Dec; 97(4):360-8. PubMed ID: 16263272
[TBL] [Abstract][Full Text] [Related]
9. MT(1) melatonin receptor overexpression enhances the growth suppressive effect of melatonin in human breast cancer cells.
Yuan L; Collins AR; Dai J; Dubocovich ML; Hill SM
Mol Cell Endocrinol; 2002 Jun; 192(1-2):147-56. PubMed ID: 12088876
[TBL] [Abstract][Full Text] [Related]
10. Direct antiproliferative effect of triptorelin on human breast cancer cells.
Marini L; Iacopino F; Schinzari G; Robustelli della Cuna FS; Mantovani G; Sica G
Anticancer Res; 1994; 14(5A):1881-5. PubMed ID: 7847821
[TBL] [Abstract][Full Text] [Related]
11. Tumor growth inhibition, apoptosis, and Bcl-2 down-regulation of MCF-7ras tumors by sodium phenylacetate and tamoxifen combination.
Adam L; Crépin M; Isräel L
Cancer Res; 1997 Mar; 57(6):1023-9. PubMed ID: 9067263
[TBL] [Abstract][Full Text] [Related]
12. Inhibitory effect of hydroxyflutamide plus tamoxifen on oestradiol-induced growth of MCF-7 breast cancer cells.
Di Monaco M; Brignardello E; Leonardi L; Gatto V; Boccuzzi G
J Cancer Res Clin Oncol; 1995; 121(12):710-4. PubMed ID: 7499441
[TBL] [Abstract][Full Text] [Related]
13. The effect of ICI 164384 and beta-interferon on the growth and steroid receptor profile of breast cancer cell lines.
Coradini D; Biffi A; Pirronello E; Di Fronzo G
Anticancer Res; 1995; 15(6B):2557-61. PubMed ID: 8669823
[TBL] [Abstract][Full Text] [Related]
14. Estrogen-signaling pathway: a link between breast cancer and melatonin oncostatic actions.
Cos S; González A; Martínez-Campa C; Mediavilla MD; Alonso-González C; Sánchez-Barceló EJ
Cancer Detect Prev; 2006; 30(2):118-28. PubMed ID: 16647824
[TBL] [Abstract][Full Text] [Related]
15. Physiological melatonin inhibition of human breast cancer cell growth in vitro: evidence for a glutathione-mediated pathway.
Blask DE; Wilson ST; Zalatan F
Cancer Res; 1997 May; 57(10):1909-14. PubMed ID: 9157984
[TBL] [Abstract][Full Text] [Related]
16. Cytostatic and cytotoxic action of Z-1, 1-dichloro-2,3-diphenylcyclopropane in three human breast cancer cell lines.
ter Haar E; Day BW
Anticancer Res; 1996; 16(3A):1107-15. PubMed ID: 8702221
[TBL] [Abstract][Full Text] [Related]
17. Tyrosine kinase inhibitors as antiproliferative agents against an estrogen-dependent breast cancer cell line in vitro.
Twaddle GM; Turbov J; Liu N; Murthy S
J Surg Oncol; 1999 Feb; 70(2):83-90. PubMed ID: 10084649
[TBL] [Abstract][Full Text] [Related]
18. Environmental magnetic fields inhibit the antiproliferative action of tamoxifen and melatonin in a human breast cancer cell line.
Harland JD; Liburdy RP
Bioelectromagnetics; 1997; 18(8):555-62. PubMed ID: 9383244
[TBL] [Abstract][Full Text] [Related]
19. 5-Fluorouracil attenuates an oncostatic effect of melatonin on estrogen-sensitive human breast cancer cells (MCF7).
Furuya Y; Yamamoto K; Kohno N; Ku Y; Saitoh Y
Cancer Lett; 1994 Jun; 81(1):95-8. PubMed ID: 8019993
[TBL] [Abstract][Full Text] [Related]
20. Effects of melatonin on the cell cycle kinetics and "estrogen-rescue" of MCF-7 human breast cancer cells in culture.
Cos S; Blask DE; Lemus-Wilson A; Hill AB
J Pineal Res; 1991 Jan; 10(1):36-42. PubMed ID: 2056430
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
